BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12878940)

  • 1. Long-term durability of the Hancock II porcine bioprosthesis.
    Rizzoli G; Bottio T; Thiene G; Toscano G; Casarotto D
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):66-74. PubMed ID: 12878940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late results of heart valve replacement with the Hancock II bioprosthesis.
    David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate results of isolated mitral valve replacement with a Biocor porcine valve.
    Rizzoli G; Bottio T; Vida V; Nesseris G; Caprili L; Thiene G; Gerosa G
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):322-9. PubMed ID: 15678042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: an 8-year experience.
    Bottio T; Rizzoli G; Thiene G; Nesseris G; Casarotto D; Gerosa G
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1616-23. PubMed ID: 15173715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.
    Wei X; Yi W; Chen W; Ma X; Lau WB; Wang H; Yi D
    Ann Thorac Surg; 2010 May; 89(5):1417-24. PubMed ID: 20417754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term follow-up in patients with Biocor porcine bioprostheses.
    Bottio T; Rizzoli G; Gerosa G; Thiene G; Casarotto D
    Cardiovasc Surg; 2002 Jun; 10(3):238-44. PubMed ID: 12044432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study.
    Kawachi Y; Tominaga R; Hisahara M; Nakashima A; Yasui H; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1561-6. PubMed ID: 1453721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-year results with the Hancock II valve: a multicenter experience.
    Rizzoli G; Mirone S; Ius P; Polesel E; Bottio T; Salvador L; Zussa C; Gerosa G; Valfrè C
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):602-9, 609.e1-4. PubMed ID: 16935116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hancock II porcine bioprosthesis: excellent durability at intermediate-term follow-up.
    Bortolotti U; Milano A; Mazzaro E; Thiene G; Talenti E; Casarotto D
    J Am Coll Cardiol; 1994 Sep; 24(3):676-82. PubMed ID: 8077538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses.
    Bloomfield P; Kitchin AH; Wheatley DJ; Walbaum PR; Lutz W; Miller HC
    Circulation; 1986 Jun; 73(6):1213-22. PubMed ID: 3516447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than ten years' follow-up of the Hancock porcine bioprosthesis in Japan.
    Kawachi Y; Tanaka J; Tominaga R; Kinoshita K; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):5-13. PubMed ID: 1614215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechanical aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis.
    Wang Y; Chen S; Shi J; Li G; Dong N
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):280-6. PubMed ID: 26675564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm evaluation of the Tissuemed (Aspire) porcine bioprosthesis: 493 patients, 506 bioprostheses.
    Goldsmith IR; Spyt TJ; Boehm M; Kendall S; Rosin MD
    Ann Thorac Surg; 2001 May; 71(5):1471-6. PubMed ID: 11383785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
    Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
    J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis.
    Poirer NC; Pelletier LC; Pellerin M; Carrier M
    Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S57-61. PubMed ID: 9930418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years.
    Jamieson WR; Munro AI; Miyagishima RT; Allen P; Burr LH; Tyers GF
    Ann Thorac Surg; 1995 Oct; 60(4):999-1006; discussion 1007. PubMed ID: 7575007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes with the Hancock II bioprosthetic valve.
    Masters RG; Haddad M; Pipe AL; Veinot JP; Mesana T
    Ann Thorac Surg; 2004 Sep; 78(3):832-6. PubMed ID: 15337001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
    Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-year durability of the aortic Hancock II bioprosthesis in young patients: is it durable enough?
    Une D; Ruel M; David TE
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):825-30. PubMed ID: 24510909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.